01Jul
Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)
At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China. Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By:
Michael Volkov
Related
The issue of willfulness is very important in FLSA cases because such a finding extends the statute ...
Read More >
In recent months, New Jersey’s Department of Labor has ramped up its efforts to crack down on emplo...
Read More >
Le 2 septembre 2020, le Bureau de la concurrence du Canada (le « Bureau ») a conclu un cadre d’appl...
Read More >
Dear YouDig?, We are in the middle of a massive addition to our warehouse. The value is high seven ...
Read More >
Labor & Employment- Massachusetts Attorney General Alleges Chipotle Served Up a Side Order of Wage ...
Read More >
Employers should review the proposals setting out no-deal Brexit plans, immigration plans if the Uni...
Read More >